Regulatory
United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention (CDC) advisory committee's formal recommendation is the next step after United States — Food and Drug Administration approval for the vaccine to be widely adopted and potentially made available for free with insurance. However, its current operations are in limbo due to a federal judge's ruling.
Stéphane Bancel: Stéphane Bancel, CEO of Moderna, expressed appreciation for the VRBPAC's review and highlighted the potential of mRNA-1010 to offer a new option for seasonal flu prevention, reinforcing the company's commitment to the vaccine.
Jun 18, 2026 · 28 articles